Navigation Links
Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
Date:9/16/2010

HAYWARD, Calif., Sept. 16 /PRNewswire/ -- The board of directors of Intarcia Therapeutics, Inc. ("Intarcia," the "Company") today announced the appointment of Kurt Graves as executive chairman of the board. In the newly created position, Mr. Graves will provide strategic leadership to the board and work closely with management as the Company seeks to advance into late stage development with its potential blockbuster asset, ITCA 650 (DUROS® continuous delivery of exenatide). His appointment follows a focused search for a highly regarded pharmaceutical executive with a track record of success based on keen market place insights, optimal commercial positioning, development and regulatory expertise, and astute business development and M&A initiatives.

(Logo:  http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO)

"I'm excited about joining Intarcia's board based on the Company's potential to make a dramatic difference in patient outcomes in one of the largest and most important disease areas in the industry – type 2 diabetes. We have two breakthrough formulation and drug delivery platforms that have translated into a highly differentiated GLP-1 asset poised to enter into phase 3 trials early next year. Final phase 2 data will be presented at EASD next week and it is now a matter of elevating our sights to the level of the opportunities before us to capture the full upside for patients and investors," said Kurt Graves, newly appointed executive chairman of the board. He added, "I am impressed with the board's and the management team's commitment to win and maximize value going forward."

Intarcia's innovations center on its capability to stabilize proteins and peptides at above body temperatures and its ability to deliver drugs in a consistent, steady state manner via the DUR
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
2. Echo Therapeutics to Present at Prestigious Accredited Members, Inc. Fall 2010 Small Cap/Micro Cap Investment Conference
3. Arcion Therapeutics Receives FDA Fast Track Designation for ARC-4558 for the Treatment of Pain Associated with Painful Diabetic Neuropathy
4. Orexigen® Therapeutics to Speak at Rodman & Renshaw Annual Global Investment Conference
5. Halozyme Therapeutics Announces Public Offering of Common Stock
6. Silence Therapeutics Issued New Patents Covering siRNA Sequences for RNA Interference Therapeutics
7. Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100
8. Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
9. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
10. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
11. Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014  In recognition of the increased ... from the flu, pneumonia, shingles and other illnesses, ... declared September to be Senior Vaccination Month. Because ... is important that adults ages 65 years and ... CVS pharmacists and MinuteClinic nurse practitioners and physician ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire/ ... market research report is available in ... Therapeutics in Asia-Pacific Markets to 2020 ... Unmet Need in Newly Diagnosed and ... http://www.reportlinker.com/p02343492/Glioblastoma-Multiforme-Therapeutics-in-Asia-Pacific-Markets-to-2020---Novel-Therapeutic-Approaches-Target-High-Unmet-Need-in-Newly-Diagnosed-and-Recurrent-GBM.html Glioblastoma ...
(Date:8/28/2014)... , Aug. 28, 2014 Telik, Inc. ... company that merged with MabVax Therapeutics, Inc. on ... significant progress related to the development of its ... was recovered using the Company,s internally developed antibody ... potential for multiple antibody based therapeutic and diagnostic ...
Breaking Medicine Technology:September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 2September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 3September is Senior Vaccination Month at CVS/pharmacy and MinuteClinic 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 2Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 3Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers 4
(Date:8/28/2014)... Chicago, IL (PRWEB) August 28, 2014 ... IT Supplement shows that while most hospitals utilize a ... of health care information technology is still a challenge. ... in the August issue of Health Affairs , ... Health Forum’s Health Care Data Center, as well as ...
(Date:8/28/2014)... The New England Journal of Medicine ... trial of a drug shown to safely reduce the ... intranasally infected with respiratory syncytial virus (RSV). ... Tennessee Health Science Center researcher Infectious Disease Specialist John ... , RSV is the most common cause of ...
(Date:8/28/2014)... change is hurting reproduction of the endangered Devils Hole pupfish, ... as few as 35 individuals, new research by the University ... report that geothermal water on a small shelf near the ... the pupfish live is heating up as a result of ... levels. , The hotter water, which now reaches more ...
(Date:8/28/2014)... smoking kills approximately 440,000 Americans each year, according ... It,s the leading cause of preventable death worldwide. ... resort to nicotine replacement therapies. , A ... University of Miami (UM) suggest that small dosages ... harmful to human musculoskeletal system, due to overuse. ...
(Date:8/28/2014)... August 28, 2014 Dr. Paul Kovatis is ... of the U.S. military for his efforts to treat many ... Wounded Warriors Foundation and several other military organizations. Dr. ... Tiger in WWII. Having five members of his immediate ... National Cemetery, it’s no wonder Dr. Kovatis is so dedicated ...
Breaking Medicine News(10 mins):Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3Health News:DeVincenzo study breakthrough in RSV research 2Health News:Climate change puts endangered Devils Hole pupfish at risk of extinction 2Health News:Climate change puts endangered Devils Hole pupfish at risk of extinction 3Health News:Are cigarette substitutes a safe alternative? It depends on user habits 2Health News:Are cigarette substitutes a safe alternative? It depends on user habits 3Health News:NJ Top Docs Presents, Dr. Paul Kovatis 2
... There just seems to be no end to the problems caused ... keep stumbling upon one disease after another caused by failure to ... list is asthma. It affects the small tubes - airways - ... ,Those obese have a 50% higher risk of developing asthma, ...
... that ‘bronzed and beautiful’ look. But unfortunately, this is not ... a report published in the Australian and New Zealand Journal ... tanning sessions are alarming. ,This is particularly so ... association between sunbed use and increased risks of melanoma, as ...
... are less likely to quit smoking, say international researchers. // ... came about through research involving the review of 31 previous ... study to analyze smoking patterns in Asia, Australia and New ... Institute for International Health , Sydney Australia and colleagues. ...
... of mostly older male veterans suffering from chronic obstructive pulmonary ... lung cancer, researchers found that regular use of high dose ... ,The results for this study appear in ... of Respiratory and Critical Care Medicine, published by the American ...
... they figure out the words' meaning for themselves, research by ... Brinster, an undergraduate student in the John Hopkins University and ... words by inference is more powerful for 3-year-olds than just ... things that is particularly exciting about the work Meredith is ...
... appropriate weight, according to current guidelines,// are four times ... have a baby who becomes overweight in early childhood. ... Department of Ambulatory Care and Prevention of Harvard Medical ... in the April issue of the American Journal of ...
Cached Medicine News:Health News:Obesity can Cause Asthma too 2Health News:Sultans of Suntans Warned 2Health News:Asian Smokers in Danger 2Health News:High-dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer 2Health News:High-dose Inhaled Corticosteroid Use for COPD Could Cut Risk of Lung Cancer 3Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 2Health News:Weight Gain in Pregnancy Linked to Overweight in Kids 3
The Biopro All Poly cup is a uniquely designed UHMWPE acetabular cup....
The Pe-Plus offers an additional clinical option for replacing the acetabulum....
BatCup cotyloid implant, designed for use in revision surgery, is an hemispherical metal cup, with grooves on the edges that house locking flanges, which are attached to the iliac bone by cancellous ...
The cementless acetabular shells form part of the Mallory head range of femoral and acetabular implants....
Medicine Products: